Back

Integrated Resistome and Quantitative Proteomics Reveal Coordinated Resistance Architecture in MDR and XDR Gram-Negative ICU Pathogens

Lima, A. A.; Silva, D.; Sherman, N. E.; Nogueira, L.; Clementino, M. A.; Havt, A.; Quirino Filho, J.; Sousa, F.; Lima, I. F. N.; Costa, D. D. S.; Ribeiro, S.; Mesquita, F.; Sousa, J.; Lino, L.; Alves, A.; Damasceno, A.; Carneiro, L.; Gondim, R.; Fragoso, L. V.; Rodrigues, J. L.; Miyajima, F.; Carvalho, B.; Maia, M. S.; Arruda, E. A. G. d.

2026-04-20 microbiology
10.64898/2026.04.15.718841 bioRxiv
Show abstract

ObjectivesAntimicrobial resistance (AMR) in Gram-negative pathogens is driven by complex and coordinated molecular mechanisms that remain incompletely characterized. This study integrated phenotypic, genomic, and quantitative proteomic analyses to characterize multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria circulating in an intensive care unit (ICU) in Northeastern Brazil. MethodsA total of 259 Gram-negative isolates collected between 2019 and 2021 underwent species identification, antimicrobial susceptibility testing, and targeted qPCR for resistance genes. Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa representing susceptible, MDR, and XDR phenotypes were selected for whole-genome sequencing and label-free quantitative proteomics. Differential protein abundance was assessed using Limma with |log2FC| > 1 and p < 0.05. ResultsK. pneumoniae (47%), A. baumannii (24%), and P. aeruginosa (21%) predominated. Carbapenem resistance reached 44%, 93%, and 61%, respectively, and MDR/XDR phenotypes occurred in >30% of isolates. Genomic analyses revealed dense resistomes with coexisting {beta}-lactamases (blaKPC, blaNDM, blaCTX-M, OXA) and widespread efflux systems. Proteomic profiling demonstrated phenotype-associated differences in outer membrane proteins, transport systems, regulatory proteins, and metabolic pathways. XDR isolates showed additional enrichment of envelope remodeling proteins, stress response mechanisms, and proteostasis-associated factors. ConclusionsMDR and XDR Gram-negative ICU pathogens exhibit coordinated resistance architecture characterized by accumulation of resistance genes and adaptive proteomic remodeling. Integrated multi-omics approaches provide mechanistic insight into antimicrobial resistance and support improved surveillance and therapeutic strategies. What is known?O_LIAntimicrobial resistance is a priority and a serious problem in global health, resulting in high rates of morbidity and mortality. C_LIO_LIKlebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa are on the World Health Organizations (WHO) priority list as major causes of morbidity and mortality worldwide. C_LIO_LIClassical characterization of susceptibility and resistance phenotypes does not capture the complexity of antimicrobial resistance and hampers effective control measures and actions to minimize the evolutionary dynamics of resistance in these bacteria. C_LI What is new?O_LIThe study characterizes the phenotypic pattern of antimicrobial susceptibility, the presence and sequencing of the resistome and virulome, and analyzes the label-free quantitative proteome of susceptible, MDR, and XDR phenotypes in strains of K. pneumoniae, A. baumannii, and P. aeruginosa circulating in hospital ICUs in Brazil. C_LIO_LIMDR and XDR gram-negative phenotypes are associated with a dense resistome, with widespread dissemination of beta-lactamase genes (bla_KPC, bla_NDM, bla_CTX-M, and OXA) and RND-type (MEXs) and acrAB-tolC efflux pumps, without changes in virulence genes. C_LIO_LIProteomic analysis demonstrated increased production of beta-lactamases, components of efflux pump systems, outer membrane protein synthesis, protection for oxidative stress mechanisms, proteins for iron acquisition, and systemic regulators. XDR strains additionally showed enhanced remodeling of the cell envelope, activation of proteostasis, and metabolic adaptation. C_LI

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
mSystems
361 papers in training set
Top 0.3%
14.6%
2
Journal of Global Antimicrobial Resistance
15 papers in training set
Top 0.1%
8.3%
3
Microbiology Spectrum
435 papers in training set
Top 0.1%
7.1%
4
mBio
750 papers in training set
Top 3%
6.3%
5
Journal of Clinical Microbiology
120 papers in training set
Top 0.6%
3.6%
6
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 0.6%
3.6%
7
Microbial Genomics
204 papers in training set
Top 0.6%
3.6%
8
Frontiers in Microbiology
375 papers in training set
Top 3%
3.6%
50% of probability mass above
9
Antibiotics
32 papers in training set
Top 0.4%
3.6%
10
PLOS ONE
4510 papers in training set
Top 42%
3.0%
11
Scientific Reports
3102 papers in training set
Top 42%
3.0%
12
Nature Communications
4913 papers in training set
Top 47%
2.1%
13
Genome Medicine
154 papers in training set
Top 4%
2.1%
14
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 2%
1.9%
15
ACS Infectious Diseases
74 papers in training set
Top 0.5%
1.9%
16
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.7%
17
Journal of Antimicrobial Chemotherapy
43 papers in training set
Top 0.2%
1.7%
18
International Journal of Antimicrobial Agents
15 papers in training set
Top 0.3%
1.6%
19
JAC-Antimicrobial Resistance
13 papers in training set
Top 0.3%
1.5%
20
mSphere
281 papers in training set
Top 4%
1.5%
21
Journal of Medical Microbiology
20 papers in training set
Top 0.4%
1.2%
22
Environmental Microbiology
119 papers in training set
Top 2%
1.2%
23
BMC Microbiology
35 papers in training set
Top 1%
0.9%
24
Water Research
74 papers in training set
Top 1%
0.9%
25
MicrobiologyOpen
18 papers in training set
Top 0.1%
0.8%
26
International Journal of Molecular Sciences
453 papers in training set
Top 17%
0.7%
27
Health Science Reports
12 papers in training set
Top 0.6%
0.6%
28
Biomedicines
66 papers in training set
Top 4%
0.6%
29
Journal of Applied Microbiology
18 papers in training set
Top 0.6%
0.6%